Esophageal Ulcer After Intravitreal Ranibizumab Injection in a Patient With Age-Related Macular Degeneration

Overview

Journal Gastroenterology Res

Specialty Gastroenterology

Date 2023 May 15

PMID 37187551

Authors

Xin Qing Li

Ke Wei Zhu

Jun Lai

Jian Wu

Xiao Fang Guo

Affiliations

Soon will be listed here.

Abstract

Ranibizumab is a monoclonal antibody fragment targeted against vascular endothelial growth factor (VEGF) A isoform (VEGF-A). This study aimed to report a case of esophageal ulcer that developed soon after intravitreal ranibizumab injection in a patient with age-related macular degeneration (AMD). A 53-year-old male patient diagnosed with AMD received ranibizumab through intravitreal injection in the left eye. Mild dysphagia occurred 3 days after receiving intravitreal ranibizumab injection for the second time. The dysphagia exacerbated remarkably and was accompanied by hemoptysis 1 day after receiving ranibizumab for the third time. Severe dysphagia accompanied by intense retrosternal pain and pant emerged after injecting ranibizumab for the fourth time. An esophageal ulcer was observed through ultrasound gastroscopy, covered with fibrinous tissue, and surrounded by flushing and congestive mucosae. The patient received proton pump inhibitor (PPI) therapy combined with traditional Chinese medicine (TCM) after discontinuation of ranibizumab. The dysphagia and retrosternal pain were gradually relieved after treatment. Afterwards, the esophageal ulcer has not relapsed since permanent discontinuation of ranibizumab. To our best knowledge, this was the first case of esophageal ulcer related to intravitreal ranibizumab injection. Our study indicated that VEGF-A played a potential role in the development of esophageal ulceration.

References

Dai X, Li J, Liu Z, Ding X, Huang C, Zhou B . Effect of Jianweiyuyang granule on gastric ulcer recurrence and expression of VEGF mRNA in the healing process of gastric ulcer in rats. World J Gastroenterol. 2005; 11(35):5480-4. PMC: 4320357. DOI: 10.3748/wjg.v11.i35.5480. View

Frampton J . Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration. Drugs Aging. 2013; 30(5):331-58. DOI: 10.1007/s40266-013-0077-9. View

Tol J, Cats A, Mol L, Koopman M, Bos M, van der Hoeven J . Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation. Invest New Drugs. 2008; 26(4):393-7. PMC: 2480515. DOI: 10.1007/s10637-008-9125-4. View

Higuchi D, Sugawa C, Shah S, Tokioka S, Lucas C . Etiology, treatment, and outcome of esophageal ulcers: a 10-year experience in an urban emergency hospital. J Gastrointest Surg. 2003; 7(7):836-42. DOI: 10.1007/s11605-003-0027-7. View

Dhoot D, Kaiser P . Ranibizumab for age-related macular degeneration. Expert Opin Biol Ther. 2012; 12(3):371-81. DOI: 10.1517/14712598.2012.660523. View

Tarnawski A . Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci. 2005; 50 Suppl 1:S24-33. DOI: 10.1007/s10620-005-2803-6. View

Meza-Junco J, Wong C, Fields A, Sawyer M . Esophageal ulcer in a patient who received bevacizumab. Invest New Drugs. 2009; 28(1):98-101. DOI: 10.1007/s10637-009-9246-4. View

Bergamo F, Lonardi S, Salmaso B, Lacognata C, Battaglin F, Cavallin F . Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients . Acta Oncol. 2017; 57(3):412-419. DOI: 10.1080/0284186X.2017.1351038. View

Nie K, Zhang Z, You Y, Zhuang X, Zhang C, Ji Y . A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer. Thorac Cancer. 2019; 11(1):8-14. PMC: 6938744. DOI: 10.1111/1759-7714.13238. View

10.

Takahashi M, Kawabe T, Ogura K, Maeda S, Mikami Y, Kaneko N . Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: a new angiogenic factor for gastric ulcer healing. Biochem Biophys Res Commun. 1997; 234(2):493-8. DOI: 10.1006/bbrc.1997.5974. View

11.

Wolfsen H, Wang K . Etiology and course of acute bleeding esophageal ulcers. J Clin Gastroenterol. 1992; 14(4):342-6. DOI: 10.1097/00004836-199206000-00015. View

12.

Cohen D, Bermont A, Richter V, Shirin H . Real world management of esophageal ulcers: analysis of their presentation, etiology, and outcomes. Acta Gastroenterol Belg. 2021; 84(3):417-422. DOI: 10.51821/84.3.004. View

13.

Libanio D, Brandao C, Pimentel-Nunes P, Dinis-Ribeiro M . Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy. GE Port J Gastroenterol. 2017; 24(6):285-287. PMC: 5731107. DOI: 10.1159/000479234. View

14.

Desideri L, Barra F, Ferrero S, Traverso C, Nicolo M . Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration. Expert Opin Biol Ther. 2019; 19(8):735-751. DOI: 10.1080/14712598.2019.1627322. View

15.

Takahashi M, Maeda S, Ogura K, Terano A, Omata M . The possible role of vascular endothelial growth factor (VEGF) in gastric ulcer healing: effect of sofalcone on VEGF release in vitro. J Clin Gastroenterol. 1999; 27 Suppl 1:S178-82. DOI: 10.1097/00004836-199800001-00029. View

16.

Martin D, Maguire M, Fine S, Ying G, Jaffe G, Grunwald J . Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results. Ophthalmology. 2020; 127(4S):S135-S145. DOI: 10.1016/j.ophtha.2020.01.029. View

17.

Bressler N . Age-related macular degeneration is the leading cause of blindness. JAMA. 2004; 291(15):1900-1. DOI: 10.1001/jama.291.15.1900. View

18.

Garcia J, Hurwitz H, Sandler A, Miles D, Coleman R, Deurloo R . Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook. Cancer Treat Rev. 2020; 86:102017. DOI: 10.1016/j.ctrv.2020.102017. View

19.

Kim Y, Park S, Kim M, Jang E, Park J, Park S . Novel single nucleotide polymorphism of the VEGF gene as a risk predictor for gastroduodenal ulcers. J Gastroenterol Hepatol. 2009; 23 Suppl 2:S131-9. DOI: 10.1111/j.1440-1746.2008.05404.x. View

20.

Dag M, Ozturk Z, Akin I, Tutar E, Cikman O, Gulsen M . Drug-induced esophageal ulcers: case series and the review of the literature. Turk J Gastroenterol. 2014; 25(2):180-4. DOI: 10.5152/tjg.2014.5415. View